Drawing for HANPOXIA

USPTO serial 79150020

HANPOXIA

Reviewed by CopyMark Law Group

Reg. 4683304Status 404
Filing date
Status date
Registration date
Feb 10, 2015
Examiner
LAMONT, MIAH ROSENBERG
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HANPOXIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

WILLIAM C. WRIGHT EPSTEIN DRANGEL LLP60 E 42ND ST STE 2410NEW YORK, NY 10165-0011UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the field of oncologySECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 29, 2024DETHDEATH OF INTERNATIONAL REGISTRATION
Aug 22, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB
Aug 2, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 2, 2022INPCINVALIDATION PROCESSED
Apr 27, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 27, 2021C71TCANCELLED SECTION 71
Feb 10, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 27, 2015FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 11, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 11, 2015FIMPFINAL DISPOSITION PROCESSED
May 10, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 10, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 25, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 5, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 20, 2014ALIEASSIGNED TO LIE
Oct 1, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 16, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 11, 2014RFNTREFUSAL PROCESSED BY IB
Aug 28, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 28, 2014RFRRREFUSAL PROCESSED BY MPU
Aug 28, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 27, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2014DOCKASSIGNED TO EXAMINER
Aug 5, 2014MAFRAPPLICATION FILING RECEIPT MAILED
Aug 1, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance